IgA protease is secreted by various mucosal pathogenic bacteria which can cleave human
immunoglobulin A1 (
IgA1) in its hinge region. In addition to be considered as a
virulence factor, it's reported that
IgA protease can also be used for
IgA nephropathy (IgAN) treatment. Our previous study identified bacteria H. influenzae 49247 expressed high activity of
IgA protease with promised application in IgAN
therapy. In this study, we cloned the
IgA protease gene of H. influenzae 49247 with degenerate primers. Alignment analysis indicated that H. influenzae 49247
IgA protease showed unique
DNA and amino acid sequence but with typical
endopeptidase domain and beta transporter domain compared with known
IgA proteases from the same species. To facilitate expression and purification, the H. influenzae 49247
IgA protease gene was sub-cloned into the pET28-A(+) vector with insertion of a 6xHis tag downstream of the
endopeptidase domain and upstream of the potential autocleavage site. The recombined
IgA protease can be constitutively expressed in E. coli and secreted into the culture medium. With a simple
nickel affinity binding, the secreted
IgA protease can be purified with high purity (95%) and a molecular weight of about 130 kDa. The identity of the
IgA protease was validated by the presence of 6xHis tag in the purified
protein by western blotting and its ability to cleave human
IgA1 molecule. Collectively, the successful cloning, expression and purification of H. influenzae 49247
IgA protease will augment its therapeutic study in IgAN treatment.